Category: Technology

NuVasive’s stock tumble on CEO departure presents buying opportunity, analyst says

WallStreetReview
NuVasive’s stock tumble on CEO departure presents buying opportunity, analyst says
Shares of NuVasive Inc. NUVA, -9.34% tumbled 9.1% in midday trade, after the spine technology company’s announcement that it was replacing its chief executive. Since NuVasive didn’t reiterated its 2018 financial guidance, Needham analyst Mike Matson suggested the big selloff is a result of investors assuming the company misses or lowers its outlook. While Matson doesn’t rule out a warning,... Read More

NuVasive CEO Lucier to step down, names Chris Barry as successor

WallStreetReview
NuVasive CEO Lucier to step down, names Chris Barry as successor
NuVasive Inc. NUVA, -1.10% said Chief Executive Gregory Lucier will step down effective Nov. 5, after 3 1/2-years in the role. He will continue as chairman of the board. The spine technology company said J. Christopher Barry will succeed Lucier as CEO. Barry is currently president of Medtronic PLC’s MDT, -1.41% Surgical Innovations business unit. The company also said Matt... Read More

Apple’s stock surges after bullish new report from Wedbush

WallStreetReview
Apple’s stock surges after bullish new report from Wedbush
Shares of Apple Inc. AAPL, -2.34% rallied 1.3% in premarket trade Friday, after Wedbush Securities started covering the technology giant with a bullish stance, citing the company’s services “gold mine” and positive iPhone cycle. Analyst Daniel Ives initiated Apple at outperform and added Apple to Wedbush’s “best ideas list.” He set a stock price target of $310, which is 44%... Read More

Merrimack Pharmaceuticals’ stock plummets toward record low after cancer drug trial terminated

WallStreetReview
Merrimack Pharmaceuticals’ stock plummets toward record low after cancer drug trial terminated
Shares of Merrimack Pharmaceuticals Inc. MACK, +2.18% plummeted 35% toward a record low in premarket trade Friday, after the biopharmaceutical company said it terminated a phase 2 trial of its non-small cell lung cancer treatment after it failed to improve progression free survival. “Since futility was observed, the decision was made to terminate the study,” the company said in a... Read More

Dow tumbles 370 points as technology and communication-services stocks tank in midday trade

WallStreetReview
Dow tumbles 370 points as technology and communication-services stocks tank in midday trade
The Dow Jones Industrial Average on Thursday fell to sessions lows, with technology and communication-services shares leading losses for the broader market. The Dow DJIA, -1.09% most recently was down 365 points, or 1.4%, at 25,351, while the technology-laden Nasdaq Composite Index COMP, -1.65% was taking it on the chin, off 1.9% at 7,497. The S&P 500 index SPX, -1.15%... Read More

Dow tumbles 350 points as technology and communication-services stocks tank in midday trade

WallStreetReview
Dow tumbles 350 points as technology and communication-services stocks tank in midday trade
The Dow Jones Industrial Average on Thursday fell to sessions lows, with technology and communication-services shares leading losses for the broader market. The Dow DJIA, -1.34% most recently was down 312 points, or 1.3%, at 25,362, while the technology-laden Nasdaq Composite Index COMP, -1.86% was taking it on the chin, off 1.9% at 7,497. The S&P 500 index SPX, -1.35%... Read More

Ticketmaster acquires blockchain technology company

WallStreetReview
Ticketmaster acquires blockchain technology company
Live Nation Entertainment Inc’s LYV, -0.37% Ticketmaster has acquired a blockchain technology company, the ticketing software company announced Thursday. The company, called UPGRADED, provides tech that converts traditional tickets into digital assets protected by blockchain. “Ticketmaster is constantly exploring emerging technologies, and there aren’t many that have the unique possibilities of blockchain,” said Justin Burleigh, chief product officer at Ticketmaster... Read More